本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Adverum Biotechnologies, Inc.

3.49
+0.16004.80%
盤後3.620.1300+3.72%19:43 EDT
成交量:75.62萬
成交額:262.50萬
市值:7,290.80萬
市盈率:-0.53
高:3.62
開:3.41
低:3.38
收:3.33
資料載入中...
2025/04/15

重要事件披露

Form 8-K - Current report
2025/04/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/31

重要事件披露

Form 8-K - Current report
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/22

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]